eu mdr interview questions

An amendment to the Regulation (EU) 2017/745 (also known as MDR) was adopted on 24 April 2020 by European Commission, which postponed the application of most of its provisions by one year, until 26 May 2021. Originally, the manufacturers of currently approved medical devices needed to meet the requirements of the regulation by May 26 2020.

A lot of questions on the compliance procedures have emerged during the transition period. In order to support manufacturers on this road to compliance, seQure has answered some of the common questions we have heard from clients and industry colleagues.

Short course on the Medical Device Regulation (EU) 2017/745

Jon is the founder and VP of QA/RA at Greenlight Guru (MedTech Lifecycle Excellence platform exclusively for medical technology companies) & a medical device guru with nearly 20 years industry experience. Jon knows the best medical device companies in the world use quality as an accelerator. Thats why he created…

Questions? Request more information from our specialists

  • Home
  • Blog
  • Top 10 European MDR Questions
  • EMERGO SUMMARY OF KEY POINTS:

  • The European Parliament’s approval of a final version of the Medical Device Regulations means companies now have a set regulatory text to help map out their compliance efforts.
  • Emergo has identified and answered 10 key questions any company affected by the EU MDR should be asking.
  • Although the MDR’s date of application isn’t until 2020, manufacturers should be focusing on their transition plans to the new Regulation now.
  • Top 10 Europe Medical Device Regulations (MDR) questionsNow that the European Parliament has voted to approve the Medical Device Regulations (MDR), many medical device companies active in Europe have begun mapping out how the new Regulations will impact their business. Based on feedback from clients as well as our own analysis of the MDR, Emergo has identified ten common industry questions and concerns regarding the EU Parliament-approved new regulation.

    Why is Post Market Surveillance an important part of the Medical Device Regulation?

    Systematic monitoring of the post market surveillance system is necessary in order to ensure detection of risk and the implementation of the action to control it, ensuring that the safety profile of the medical device product is always updated.

    The future implementation of the EU MDR has increased the barriers to entry in the European Union (EU), and apparently more Medtech companies are looking to other alternative markets (e.g., US, Asia, Latin America) to first initiate their commercial activities. These are some of the questions that come to mind around the topic (you don’t have to share confidential information):

    FAQ

    What are the key elements in the MDR?

    Defining MDR services

    MDR services are delivered in a variety of ways, though the industry seems to agree on the following elements as the most basic deliverables of an MDR service: proactive response. cyberthreat hunting. 24/7 operations.

    What are the new EU MDR requirements?

    Manufacturers are now required to conduct post-market surveillance on devices in order to monitor their safety and performance, which must be compliant with European Union law and report any defects with these products.

    What is the difference between EU MDR and EU?

    The EU MDR is the set of regulations that governs the production and distribution of medical devices in Europe. Compliance with this regulation is mandatory for medical device companies (legal manufacturers) that want to market or sell their products in the EEA (European Economic Area).

    Related Posts

    Leave a Reply

    Your email address will not be published. Required fields are marked *